The Academy posted a news article last month about an FDA effort to solicit patient feedback specifically in the area of “treatments for moderate to severe hearing loss (implanted vs. other treatment options).” To that end, the Academy’s Government Relations Committee authored the Patient Survey so that practitioners could print the document and provide it to their patients. The survey document includes specific instructions so that patients can complete the survey and then mail their responses directly to the FDA.
The FDA is hoping to glean from this feedback whether patients prefer certain outcomes or choices over others in terms of their health. In addition, the FDA wants to understand how patients view the risks and benefits of a technology or treatment differently from how the risk and benefits are viewed by health-care professionals and caregivers and whether differences in patient perspectives are not well understood due to a variety of factors.
Patient feedback should be postmarked on or before July 2, 2019.
Related Posts
Telehealth HIPAA Compliance Flexibilities Extended as the Public Health Emergency Ends
During the COVID-19 public health emergency (PHE), many federal telehealth rules were made flexible to accommodate the need for continued access to health care, including allowing covered health-care providers to provide telehealth services to patients through remote technologies that may not have fully complied with the requirements of the Health Information Portability and Accountability Act…
Congressional Budget Office Publishes New Health Insurance Coverage Projections
The Congressional Budget Office (CBO) has released updated projections of health insurance coverage through 2033 for people younger than age 65 over. The share of Americans younger than age 65 who are uninsured is currently at a historic low of 8.3 percent. CBO attributes this to temporary policies instituted in response to the COVID-19 pandemic,…
Academy Recommends Changes to Proposed Amendments to New York EHDI Screening Protocol
The New York Department of Health recently proposed shifting to a two-tiered testing protocol in the New York Universal Newborn Hearing Screening Programs (UNHS) to “be consistent with nationally recognized standards established by the Joint Committee of Infant Hearing (JCIH).” The New York proposal would mandate utilizing an otoacoustic emissions (OAE) screening followed by an…